Impact Biomedicines
Latest round
- Series A
Last raised
- Oct 2017
Total raised
- $22M
Investors
- 1
About Impact Biomedicines
Impact Biomedicines, Inc. is a biotechnology company focused on developing innovative therapies for serious diseases, particularly in the field of oncology.Founded in 2016 and headquartered in San Diego, US, Impact Biomedicines, Inc. specializes in developing biopharmaceuticals.Impact Biomedicines, Inc. is part of Bristol Myers Squibb, a global biopharmaceutical company dedicated to discovering, developing, and delivering medications for serious diseases.Bristol Myers Squibb generates revenue primarily through direct sales to healthcare providers and partnerships with pharmaceutical retailers. Their revenue structure is based on proprietary product sales, including flagship medications that are purchased by healthcare institutions under established pricing agreements.Following the most recent deal in January 2018, which involves a strategic acquisition by Celgene, Impact Biomedicines, Inc. is poised to enhance its product offerings and expand its market presence. The company plans to utilize the USD 1100 mn from this acquisition to support the development of new therapies and potentially enter untapped markets in Europe and Asia by 2020.
Who invested in Impact Biomedicines
1 investor across 1 round
See all investors in Impact Biomedicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 13, 2017
Amount
$22M
Investors
Questions about Impact Biomedicines
Who invested in Impact Biomedicines?
Impact Biomedicines has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Impact Biomedicines raised?
Impact Biomedicines has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Impact Biomedicines last raise money?
Impact Biomedicines's most recent round on record is a Series A, in Oct 2017.
What does Impact Biomedicines do?
Impact Biomedicines is a healthcare company.
Where is Impact Biomedicines headquartered?
Impact Biomedicines is headquartered in San Diego, US.
Which VCs invest in companies like Impact Biomedicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Impact Biomedicines's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Impact Biomedicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.